| 000 | 01719 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516141007.0 | ||
| 264 | 0 | _c20130520 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1460-2105 | ||
| 024 | 7 |
_a10.1093/jnci/djt032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeval, Amy | |
| 245 | 0 | 0 |
_aQuadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cApr 2013 |
||
| 300 |
_a469-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAlphapapillomavirus _ximmunology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCondylomata Acuminata _xepidemiology |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xepidemiology |
| 650 | 0 | 4 |
_aPapillomavirus Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 650 | 0 | 4 |
_aSweden _xepidemiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHerweijer, Eva | |
| 700 | 1 | _aPloner, Alexander | |
| 700 | 1 | _aEloranta, Sandra | |
| 700 | 1 | _aFridman Simard, Julia | |
| 700 | 1 | _aDillner, Joakim | |
| 700 | 1 | _aYoung, Cecilia | |
| 700 | 1 | _aNetterlid, Eva | |
| 700 | 1 | _aSparén, Pär | |
| 700 | 1 | _aArnheim-Dahlström, Lisen | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 105 _gno. 7 _gp. 469-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/djt032 _zAvailable from publisher's website |
| 999 |
_c22578056 _d22578056 |
||